Curated Health Wellness News

NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.

ABVC BioPharma Secures Patent Approval for ADHD Treatment in Taiwan

January 2, 2025ABVC BioPharma secures patent approval in Taiwan for Polygala Extract to treat ADHD, reinforcing its global intellectual property portfolio. The company's innovative treatment targets ADHD core symptoms through Norepinephrine Transporter inhibition, with plans to expand globally and improve outcomes for patients worldwide.


SaveRxCanada.to Introduces Free Shipping for RxSelect Program in 2025

January 2, 2025SaveRxCanada.to launches free shipping for RxSelect program in 2025, offering affordable generic medications to customers worldwide. Save up to 80% on prescription drugs compared to U.S. prices. Learn more about this initiative for enhanced medication access and affordability.


Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. for Q3 2024

December 29, 2024Stonegate Capital Partners provides an update on Bio-Path Holdings, Inc. for Q3 2024, emphasizing the company's innovative drug candidates and breakthrough technology in cancer treatment. With a strong IP position and strategic relationships, Bio-Path is poised for success and potential growth in the biopharmaceutical industry.


Clene Receives FDA Guidance for Accelerated Approval Pathway for CNM-Au8 in ALS

December 27, 2024Clene (NASDAQ: CLNN) and its subsidiary, Clene Nanomedicine Inc., received FDA guidance for potential accelerated approval of their lead drug candidate CNM-Au8 in ALS. The guidance followed a Type C meeting where Clene presented additional clinical trial data and analyses. Clene plans to submit an NDA under the accelerated approval pathway in mid-2025.


Securities Class Action Lawsuit Filed Against Applied Therapeutics, Inc.

December 26, 2024Learn about the securities class action lawsuit filed by Kessler Topaz Meltzer & Check, LLP against Applied Therapeutics, Inc. Allegations include failure to adhere to trial protocol for the drug candidate govorestat, posing a risk of FDA rejection. Investors have until February 18, 2025, to seek appointment as a lead plaintiff.


LogicMark Launches Critical New Device to Save Lives

December 24, 2024Chia-Lin Simmons, CEO of LogicMark, discusses the launch of the new premiere safety smartphone, the Freedom Alert Max, in an interview with Benzinga’s All-Access. LogicMark is a leading provider of personal emergency response systems (PERS), health communications devices, and IoT technologies, aiming to create a connected care platform to keep at-risk populations safe.


Study Reveals Socioeconomic Disparity in Cancer Patient Life Expectancy

December 24, 2024Recent study in New South Wales, Australia reveals significant socioeconomic disparity in cancer patient life expectancy. Urgent need to address healthcare disparities and improve access to early detection, quality treatment, and survivorship care for all patients.